Skip to content
Triangle logo TriangleGet started
← Full study record

NCT01204788 · OUTCOME

Number of Participants With Infection

Prophylactic White Cell Transfusions Versus Therapeutic White Cell Transfusions in Patients With Leukemia · Source last updated 2015-06-10

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

Measure
Not reported
Unit
Not reported
Interval / dispersion
Not reported
Time frame
Blood draw 2-3 times a week while hospitalized, weekly thereafter. Participant to remain on study 42 days after transfusion.

What was measured

Primary outcome is infection (yes/no) where participant without infection found by day 42 patient are counted as 'No' to infection.

Analysis population: Outcomes inevaluable due to low recruitment.

Groups in this outcome

Arm 1 (Prophylactic Arm)

Prophylactic Treatment (standard of care prophylactic antibiotics) + Prophylactic White Cell Transfusion. Radiated white blood cell transfusions 2-3 times each week, or daily if infection develops

Arm 2 (Therapeutic Arm)

Prophylactic Treatment (standard of care prophylactic antibiotics) + Therapeutic White Cell Transfusion. Radiated white blood cell transfusions daily only with infection (or persistent fever)

Group identifiers and denominators belong to this outcome only. They may differ in another outcome or in safety reporting.

Analysis denominator · Participants

GroupSource count
Arm 1 (Prophylactic Arm)0
Arm 2 (Therapeutic Arm)0

Reported measurements

No numerical measurement classes were posted for this outcome. Missing is not zero.

Complete source fields
denoms
  1. counts
    1. group Id
      OG000
      value
      0
    2. group Id
      OG001
      value
      0
    units
    Participants
description
Primary outcome is infection (yes/no) where participant without infection found by day 42 patient are counted as 'No' to infection.
groups
  1. description
    Prophylactic Treatment (standard of care prophylactic antibiotics) + Prophylactic White Cell Transfusion. Radiated white blood cell transfusions 2-3 times each week, or daily if infection develops
    id
    OG000
    title
    Arm 1 (Prophylactic Arm)
  2. description
    Prophylactic Treatment (standard of care prophylactic antibiotics) + Therapeutic White Cell Transfusion. Radiated white blood cell transfusions daily only with infection (or persistent fever)
    id
    OG001
    title
    Arm 2 (Therapeutic Arm)
population Description
Outcomes inevaluable due to low recruitment.
reporting Status
POSTED
time Frame
Blood draw 2-3 times a week while hospitalized, weekly thereafter. Participant to remain on study 42 days after transfusion.
title
Number of Participants With Infection
type
PRIMARY

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice